CRY: CryoLife, Inc. StockTalks

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, April 30, 8:22 AM CryoLife (CRY): Q1 EPS of $0.08 beats by $0.01. Revenue of $35.5M (+10% Y/Y) beats by $0.46M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, April 4, 8:45 AM CryoLife (CRY) looks set to open higher after announcing it has received FDA approval for a new long-term vascular access device (HeRO) which the company will launch in Q4 after validating its manufacturing processes. Shares +4.8% premarket. Comment! [Healthcare, On the Move]
Thursday, February 14, 1:02 PM CryoLife (CRY +3.2%) moves up after posting mixed Q4 results this morning, beating on its EPS but coming up shy on revenue. For FY13, it sees revenues between $139M and $143M and its EPS between $0.25 and $0.28. Additionally, its Board approved a $15M stock buyback through October 31, 2014. Comment! [Healthcare, Earnings, On the Move]
Thursday, February 14, 8:22 AM CryoLife (CRY): Q4 EPS of $0.08 beats by $0.02. Revenue of $32.8M (+8% Y/Y) misses by $0.78M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Wednesday, February 13, 9:18 AM Cryolife Inc (CRY) declares $0.025/share quarterly dividend, in line with previous. Forward yield 1.66%. For shareholders of record Mar. 14. Payable Mar. 21. Ex-div date Mar. 12. (PR) Comment! [Dividends]
Monday, November 19, 2012, 9:29 AM CryoLife, Inc. (CRY) declares $0.025/share quarterly dividend, in line with previous. Forward yield 1.76%. For shareholders of record Dec. 14. Payable Dec. 21. Ex-div Dec. 12. (PR) 1 Comment [Dividends]
Tuesday, October 30, 2012, 8:18 AM CryoLife (CRY): Q3 EPS of $0.08 beats by $0.04. Revenue of $33.4M (+12.5% Y/Y). (PR) Comment! [Earnings, Healthcare]
Tuesday, August 21, 2012, 8:47 AM CryoLife (CRY) declared its first-ever quarterly dividend of $0.025/share. Forward yield 1.86%. For shareholders of record Sep 14. Payable Sep 21. Ex-div date Sep 12. (PR) Comment! [Dividends]
Monday, August 6, 2012, 12:37 PM CryoLife (CRY -3%) slides after Benchmark cut the shares to hold this morning, citing delays in the clinical trial of PerClot and the impact that lower R&D spending in the current year is going to have on future earnings performance. Comment! [Healthcare, On the Move]
Tuesday, July 31, 2012, 1:38 PM CryoLife (CRY +8.8%) a tissue processing and medical device company, pops after blowing away its Q2 earnings estimates and raising its FY12 guidance. The company sees fiscal year revenues of $129M to $133M, versus analysts estimates of $132M. Comment! [Healthcare, Earnings, On the Move]
Tuesday, July 31, 2012, 9:03 AM CryoLife (CRY): Q2 EPS of $0.1 beats by $0.05. Revenue of $33.2M (+12.9% Y/Y) beats by $0.41M. Shares +10.8% premarket. (PR) Comment! [Earnings, On the Move]
Thursday, April 26, 2012, 9:37 AM CryoLife (CRY): Q1 EPS of $0.04 misses by $0.01. Revenue of $32.3M (+7% Y/Y) beats by $1.4M. (PR) Comment! [Earnings, Healthcare]
Thursday, February 16, 2012, 8:35 AM CryoLife (CRY): Q4 EPS of $0.07 beats by $0.01. Revenue of $30.4M (+4.1% Y/Y) misses by $1M. (PR) Comment! [Earnings, Healthcare]
Wednesday, August 12, 2009, 9:00 AM Premarket gainers: EJ +21%. JAZZ +195. TSEM +14%. ADCT +12%. TOL +9%. CRY +8%. BZH +5%. RBS +4%.
Losers: JASO -10%. LIZ -9%. YRCW -7%. IMAX -6%. Comment!

CRY CryoLife, Inc.

CRY

CryoLife, Inc.